NCT00099229已完成3 期
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Tolerability of Licarbazepine 1000-2000mg/Day in the Treatment of Manic Episodes of Bipolar I Disorder Over 3 Weeks
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 320
- 试验地点
- 22
- 主要终点
- Mean reduction in manic episodes and major depressive episodes from baseline to endpoint (Week 3).
研究概览
简要总结
This purpose of this study is to evaluate the safety and efficacy of Licarbazepine for the treatment of manic episodes of bipolar disorder.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of bipolar disorder (type I) with manic or mixed episodes (including patients with/without psychotic features or with/without a history of rapid cycling)
- •In need of psychiatric treatment
- •Cooperation and willingness to complete all aspects of the study
排除标准
- •Current diagnosis other than bipolar I disorder
- •History of schizophrenia or schizoaffective disorder
- •Drug dependence within 1 month prior to study start or testing positive in a urine drug test
- •Suicide attempt within 1 month prior to study start or at immediate risk of harm to self or others
- •Any form of psychotherapy within 1 month prior to study start
结局指标
主要结局
Mean reduction in manic episodes and major depressive episodes from baseline to endpoint (Week 3).
次要结局
- Major improvement in anxiety and depression from baseline to endpoint (Week 3)
研究者
研究点 (22)
Loading locations...
相似试验
已完成
4 期
Antiepileptic Drug Carbamazepine in Treatment of Bronchial AsthmaBronchial AsthmaNCT00207428Centre of Chinese Medicine, Georgia65
已完成
3 期
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With SchizophreniaSchizophreniaNCT01412060Forest Laboratories765
已完成
3 期
Safety and Efficacy of Cariprazine for Bipolar I DisorderManiaBipolar I DisorderNCT01058668Forest Laboratories497
已完成
3 期
Safety and Efficacy of Cariprazine for ManiaManiaBipolar DisorderNCT01058096Forest Laboratories323
已完成
3 期
The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants AloneMajor Depressive DisorderNCT03739203AbbVie752